glp 1 trapezoid Tirzepatide (TZP) differentially induces internalization of the GIP and GLP-1-based therapies for diabetes, obesity

Carotenoids are part of the major group of lipophilic antioxidants and are essential in managing diseases associated with oxidative stress and aging, such as AMD

The liver is the body's largest reservoir for glutathione

Thiamine is crucial for energy metabolism, and its deficiency can cause severe neurological and cardiac disorders

Amgen has developed a GLP-1/GIP drug that is given monthly, while Intracia is working on an agent that is injected every six months

Effect of various carbohydrate-electrolyte fluids on cycling performance and maximal voluntary contraction

Semaglutide (SUSTAIN and PIONEER) Reduces Cardiovascular Events in Type 2 Diabetes Across Varying Cardiovascular Risk